Masimo (MASI) Competitors $160.04 -1.65 (-1.02%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$164.00 +3.96 (+2.47%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MASI vs. AMN, VEEV, DXCM, STE, PODD, BAX, HOLX, GMED, TFX, and ITGRShould you be buying Masimo stock or one of its competitors? The main competitors of Masimo include AMN Healthcare Services (AMN), Veeva Systems (VEEV), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), Teleflex (TFX), and Integer (ITGR). These companies are all part of the "medical" sector. Masimo vs. Its Competitors AMN Healthcare Services Veeva Systems DexCom STERIS Insulet Baxter International Hologic Globus Medical Teleflex Integer Masimo (NASDAQ:MASI) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment. Do analysts rate MASI or AMN? Masimo presently has a consensus price target of $191.60, indicating a potential upside of 19.72%. AMN Healthcare Services has a consensus price target of $32.08, indicating a potential upside of 61.10%. Given AMN Healthcare Services' higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than Masimo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83AMN Healthcare Services 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is MASI or AMN more profitable? AMN Healthcare Services has a net margin of -5.80% compared to Masimo's net margin of -25.06%. Masimo's return on equity of 22.56% beat AMN Healthcare Services' return on equity.Company Net Margins Return on Equity Return on Assets Masimo-25.06% 22.56% 10.00% AMN Healthcare Services -5.80%13.39%4.17% Which has better earnings and valuation, MASI or AMN? AMN Healthcare Services has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMasimo$2.09B4.14-$304.90M-$9.17-17.45AMN Healthcare Services$2.98B0.26-$146.98M-$4.33-4.60 Which has more risk and volatility, MASI or AMN? Masimo has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.18, suggesting that its stock price is 82% less volatile than the S&P 500. Does the media prefer MASI or AMN? In the previous week, Masimo had 1 more articles in the media than AMN Healthcare Services. MarketBeat recorded 5 mentions for Masimo and 4 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.85 beat Masimo's score of 0.73 indicating that AMN Healthcare Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Masimo 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in MASI or AMN? 86.0% of Masimo shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 16.9% of Masimo shares are held by insiders. Comparatively, 0.9% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryMasimo and AMN Healthcare Services tied by winning 8 of the 16 factors compared between the two stocks. Get Masimo News Delivered to You Automatically Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASI vs. The Competition Export to ExcelMetricMasimoMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.77B$6.76B$5.61B$9.29BDividend YieldN/A1.21%4.23%4.03%P/E Ratio-17.4525.9728.5419.58Price / Sales4.1461.63429.2495.01Price / Cash25.3120.3636.0257.93Price / Book8.214.638.145.54Net Income-$304.90M$174.76M$3.24B$257.73M7 Day Performance-3.25%-3.25%0.18%-0.08%1 Month Performance-1.54%-0.33%5.96%8.09%1 Year Performance45.65%0.36%26.24%13.02% Masimo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASIMasimo4.1907 of 5 stars$160.04-1.0%$191.60+19.7%+47.0%$8.77B$2.09B-17.455,600AMNAMN Healthcare Services4.236 of 5 stars$21.23-3.1%$32.08+51.1%-61.5%$812.68M$2.98B-4.902,968VEEVVeeva Systems3.9468 of 5 stars$281.30-1.1%$269.80-4.1%+50.4%$45.97B$2.75B59.607,291Positive NewsAnalyst ForecastDXCMDexCom4.7857 of 5 stars$82.94+0.0%$98.50+18.8%-25.0%$32.52B$4.03B61.9010,300Positive NewsAnalyst ForecastSTESTERIS4.8617 of 5 stars$233.09-1.9%$263.83+13.2%+3.8%$22.93B$5.46B37.6017,787Positive NewsAnalyst UpgradeAnalyst RevisionPODDInsulet4.5609 of 5 stars$300.70-0.1%$321.00+6.8%+45.8%$21.16B$2.20B54.083,900Positive NewsAnalyst RevisionBAXBaxter International4.5825 of 5 stars$29.70-4.2%$36.14+21.7%-16.9%$15.24B$10.64B-27.0038,000Dividend AnnouncementAnalyst ForecastHOLXHologic4.7517 of 5 stars$64.37-0.6%$77.42+20.3%-18.2%$14.34B$4.03B27.167,063Positive NewsGMEDGlobus Medical4.9609 of 5 stars$55.99-5.4%$94.00+67.9%-22.5%$7.58B$2.52B41.785,300News CoverageAnalyst ForecastTFXTeleflex4.5859 of 5 stars$116.76-2.6%$164.63+41.0%-48.4%$5.16B$3.05B36.8314,100Analyst ForecastITGRInteger3.177 of 5 stars$117.05-3.3%$145.00+23.9%-2.0%$4.08B$1.72B55.4711,000News Coverage Related Companies and Tools Related Companies AMN Healthcare Services Alternatives Veeva Systems Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Hologic Alternatives Globus Medical Alternatives Teleflex Alternatives Integer Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MASI) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Masimo Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Masimo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MASI Stock Alerts